candesartan has been researched along with glutamic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, S; Kido, H; Morimoto, S; Nakagawa, M; Oguni, A; Sasaki, S; Takeda, K | 1 |
| Clinckers, R; De Bundel, D; Ebinger, G; Meurs, A; Michotte, Y; Sarre, S; Smolders, I; Stragier, B | 1 |
| Gabor, A; Leenen, FH | 2 |
| Elkahloun, AG; Hafko, R; Saavedra, JM | 1 |
| Elkahloun, AG; Saavedra, JM | 1 |
6 other study(ies) available for candesartan and glutamic acid
| Article | Year |
|---|---|
Effects of angiotensin II type 1 receptor antagonist on pressor responses to pulsatile compression of the rostral ventrolateral medulla in rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Excitatory Amino Acid Antagonists; Glutamic Acid; Hypertension; Imidazoles; Injections, Intravenous; Kynurenic Acid; Male; Medulla Oblongata; Pulsatile Flow; Pyridines; Rats; Rats, Wistar; Sympathetic Nervous System; Tetrazoles; Vasoconstrictor Agents | 2004 |
Involvement of the somatostatin-2 receptor in the anti-convulsant effect of angiotensin IV against pilocarpine-induced limbic seizures in rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anticonvulsants; Benzimidazoles; Biphenyl Compounds; Dopamine; Glutamic Acid; Hippocampus; Injections, Intraventricular; Limbic System; Male; Microdialysis; Oligopeptides; Pilocarpine; Rats; Rats, Wistar; Receptors, Somatostatin; Seizures; Serotonin; Somatostatin; Tetrazoles | 2006 |
Cardiovascular effects of angiotensin II and glutamate in the PVN of Dahl salt-sensitive rats.
Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Glutamic Acid; Heart Rate; Kynurenic Acid; Male; Paraventricular Hypothalamic Nucleus; Rats; Rats, Inbred Dahl; Receptors, Angiotensin; Tetrazoles | 2012 |
Central mineralocorticoid receptors and the role of angiotensin II and glutamate in the paraventricular nucleus of rats with angiotensin II-induced hypertension.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Disease Models, Animal; Eplerenone; Glutamic Acid; Heart Rate; Hypertension; Infusions, Intravenous; Infusions, Intraventricular; Kynurenic Acid; Male; Mineralocorticoid Receptor Antagonists; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Glutamate; Receptors, Mineralocorticoid; Signal Transduction; Spironolactone; Tetrazoles | 2013 |
An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Cerebellum; Databases, Factual; Disease Models, Animal; Gene Expression Profiling; Glutamic Acid; Hippocampus; Humans; Inflammation Mediators; Neurons; Neuroprotective Agents; Rats, Sprague-Dawley; Signal Transduction; Tetrazoles; Transcriptome | 2016 |
Candesartan Neuroprotection in Rat Primary Neurons Negatively Correlates with Aging and Senescence: a Transcriptomic Analysis.
Topics: Aging; Animals; Benzimidazoles; Biphenyl Compounds; Cellular Senescence; Glutamic Acid; Hippocampus; Neurons; Neuroprotection; Oxidative Stress; Rats; Tetrazoles; Transcriptome | 2020 |